SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-021505
Filing Date
2022-11-03
Accepted
2022-11-03 06:37:01
Documents
13
Period of Report
2022-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krtx-20221103.htm   iXBRL 8-K 55906
2 EX-99.1 krtx-ex99_1.htm EX-99.1 215862
  Complete submission text file 0000950170-22-021505.txt   400379

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krtx-20221103_pre.xml EX-101.PRE 9892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krtx-20221103_lab.xml EX-101.LAB 13474
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krtx-20221103.xsd EX-101.SCH 2457
7 EXTRACTED XBRL INSTANCE DOCUMENT krtx-20221103_htm.xml XML 4747
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38958 | Film No.: 221356052
SIC: 2834 Pharmaceutical Preparations